Prof. Götz is Director of the Institute of Stem Cell Research at Helmholtz Center Munich and Chair of Physiological Genomics at Ludwig-Maximilians-Universität, Munich
Vevzuo is authorized for the prevention of skeletal related events in adults with advanced malignancies involving bone
Star Health Insurance is modernising its claims ecosystem to be future-ready
The CR Bio unit represents a non-core legacy asset with limited strategic alignment to our core CDMO operations
The proceeds from the QIP will be utiized for purchase of outstanding optionally convertible debentures
The project will be instrumental in enhancing the company's API manufacturing capacity and global reach
The partnership combines Boehringer’s expertise in canine cardiology with Eko’s digital stethoscopes and AI algorithms
AMPLIFY Phase III trial results demonstrated statistically significant and clinically meaningful improvement in progression-free survival for Calquence combinations
Aumolertinib can be used in patients who have tested positive for a mutation in a gene called epidermal growth factor receptor
Subscribe To Our Newsletter & Stay Updated
